Download PDF
Thromb Haemost 1977; 38(04): 1085-1096
DOI: 10.1055/s-0038-1651925
Original Article
Schattauer GmbH

The Role of Platelets in the Pathogenesis of Thrombosis and Hemorrhage in Patients with Thrombocytosis

Peter N. Walsh
*   Specialized Center on Thrombosis Research, Philadelphia, Pennsylvania, U.S.A.
,
Scott Murphy
**   Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, U.S.A.
,
William E. Barry
***   Cardeza Foundation, Thomas Jefferson School of Medicine, Philadelphia, Pennsylvania, U.S.A.
› Author Affiliations
Further Information

Publication History

Publication Date:
04 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

Some patients with thrombocytosis due to myeloproliferative diseases or other etiologies experience thromboembolic complications and others may bleed excessively. It seems unlikely that elevations in platelet count per se are a direct cause either of thrombosis or of hemorrhage. In an effort to ascertain whether variations in platelet function might determine whether an individual patient experiences thrombotic or hemorrhagic complications we have evaluated platelet function in 22patients with thrombocytosis due to a variety of etiologies. The results of platelet counts, bleeding time determinations, and studies of platelet aggregation were similar in patients with thrombosis, in patients with bleeding and in patients with neither complication. Therefore, detailed studies of platelet coagulant activities were carried out in 8patients. The results of platelet coagulant activity assays were normal in all 3patients with thrombocytosis and neither thrombotic nor bleeding complications and an additional 3patients with myeloproliferative diseases, normal platelet counts and no thrombohemorrhagic complications. In 2patients with thrombotic complications significant elevation of platelet coagulant activities concerned with the early phases of intrinsic coagulation were observed whereas in 2patients with severe hemorrhagic complications deficiences of either contact forming activity or collagen-induced coagulant activities were evident. This preliminary study suggests the possibility that variations in platelet coagulant activities concerned with the early stages of intrinsic coagulation may determine whether patients with thrombocytosis will experience bleeding or thrombotic complications.

 

  • References

  • 1 Adams T, Schutz L, Goldberg L. 1974; Platelet function abnormalities in the myeloproliferative disorders. Scandinavian Journal of Haematology 13: 215.
    PubMedSearch in Google Scholar
  • 2 Barbui T, Battista R, Dini E. 1973; Spontaneous platelet aggregation in myeloproliferative disorders. Acta Haematologica 50: 25.
    CrossrefPubMedSearch in Google Scholar
  • 3 Bensinger T. A, Logue G. L, Rundles R. W. 1970; Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan. Blood 36: 61.
    PubMedSearch in Google Scholar
  • 4 Berger S, Aledort L. M, Gilbert H. S, Hanson J. P, Wasserman L. R. 1973; Abnormalities of platelet function in patients with polycythemia vera. Cancer Research 33: 2683.
    PubMedSearch in Google Scholar
  • 5 Bigelow F. S. 1954; Serotonin activity in blood: Measurements in normal subjects and in patients with thrombocythemia hemorrhagica and other hemorrhagic states. Journal of Laboratory and Clinical Medicine 43: 759.
    PubMedSearch in Google Scholar
  • 6 Boughton B. J, Corbett W. E. N, Ginsburg A. D. 1977; Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function. Journal of Clinical Pathology 30: 228.
    CrossrefPubMedSearch in Google Scholar
  • 7 Brecher G, Cronkite E. P. 1950; Morphology and enumeration of human blood platelets. Journal of Applied Physiology 3: 365.
    CrossrefPubMedSearch in Google Scholar
  • 8 Brodsky I, Ross E. M, Petkov G, Kahn S. B. 1972; b Platelet and fibrinogen kinetics with [75Se]-Selenomethionine in patients with myeloproliferative disorders. British Journal of Haematology 22: 179.
    CrossrefPubMedSearch in Google Scholar
  • 9 Brodsky I, Kahn S. B, Ross E. M, Petkov G. 1972; a Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders. Cancer 30: 1444.
    CrossrefPubMedSearch in Google Scholar
  • 10 Cardamone J. M, Edson J. R, McArthur J. R, Jacob H. S. 1972; Abnormalities of platelet function in myeloproliferative disorders. Journal of the American Medical Association 221: 270.
    CrossrefPubMedSearch in Google Scholar
  • 11 Cohen I, Djaldetti M, Karp M, De Vries A. 1966; Thrombocytosis with impaired platelet adhesiveness and platelet factor 3 availability. New Istanbul Contributions to the Clinical Sciences 9: 20.
    PubMedSearch in Google Scholar
  • 12 Dawson A. A, Ogston D. 1970; The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythemia vera. Postgraduate Medical Journal 46: 76.
    CrossrefPubMedSearch in Google Scholar
  • 13 Didisheim P, Bunting D. 1966; Abnormal platelet function in myelofibrosis. The American Journal of Clinical Pathology 45: 566.
    PubMedSearch in Google Scholar
  • 14 Drummond A. H, Gordon J. L. 1974; A rapid, sensitive microassay for platelet 5-HT. Thrombosis et Diathesis Haemorrhagica 31: 366.
    PubMedSearch in Google Scholar
  • 15 Epstein E, Goedel A. 1934; Hämorrhagische Thrombocythämie bei vasculärer Schrumpfmilz. Virchows Archiv 292: 233.
    CrossrefPubMedSearch in Google Scholar
  • 16 Gilbert H. S. 1975; Definition, clinical features and diagnosis of polycythaemia vera. Clinics in Haematology 4: 263.
    PubMedSearch in Google Scholar
  • 17 Ginsburg A. D. 1974. Thrombocytosis and thrombocythemia. In: Physiological Pharmacology. Vol. V. Blood. (eds.) Root W. S, Berlin N. I. Academic Press; New York: 199-235.
    Search in Google Scholar
  • 18 Ginsburg A. D. 1975; Platelet function in patients with high platelet counts. Annals of Internal Medicine 82: 506.
    CrossrefPubMedSearch in Google Scholar
  • 19 Gunz F. W. 1960; Hemorrhagic thrombocythemia: A critical review. Blood 15: 706.
    PubMedSearch in Google Scholar
  • 20 Gunz F. W. 1972. Essential thrombocythemia, Chapter 83. In: Hematology. (eds.) Williams W. J, Beutler E, Erslev A. J, Rundles R. W. McGraw-Hill Book Co.; New York: 704.
    Search in Google Scholar
  • 21 Hardistry R. M, Wolff H. H. 1955; Haemorrhagic thrombocythaemia: a clinical and laboratory study. British Journal of Haematology 1: 390.
    CrossrefPubMedSearch in Google Scholar
  • 22 Harker L. A, Finch C. A. 1969; Thrombokinetics in man. Journal of Clinical Investigation 48: 963.
    CrossrefPubMedSearch in Google Scholar
  • 23 Hirsh J, Dacie J. V. 1966; Persistent postsplenectomy thrombocytosis and thromboembolism: a consequence of continuing anaemia. British Journal of Haematology 12: 44.
    CrossrefPubMedSearch in Google Scholar
  • 24 Holmsen H, Østvold A.-C, Day H. J. 1973; Behavior of endogenous and newly absorbed serotonin in the platelet release reaction. Biochemical Pharmacology 22: 2599.
    CrossrefPubMedSearch in Google Scholar
  • 25 Inceman S, Tangun Y. 1972; Platelet defects in the myeloproliferative disorders. Annals of the New York Academy of Science 201: 251.
    CrossrefPubMedSearch in Google Scholar
  • 26 Kutti J, Weinfeld A. 1971; Platelet survival in active polycythaemia vera with reference to the haematocrit level. Scandinavian Journal of Haematology 8: 405.
    PubMedSearch in Google Scholar
  • 27 Laszlo J. 1975; Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocythemia. Seminars in Hematology 12: 409.
    PubMedSearch in Google Scholar
  • 28 Martinez J, Shapiro S. S, Holburn R. R. 1973; Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states. Blood 42: 35.
    PubMedSearch in Google Scholar
  • 29 Mason Jr J. E, De Vita V. T, Canellos G. P. 1974; Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. Blood 44: 438.
    PubMedSearch in Google Scholar
  • 30 McClure P. D, Ingram G. I. C, Stacey R. S, Glass U. H, Matchett M. O. 1966; Platelet function test in thrombocythaemia and thrombocytosis. British Journal of Haematology 12: 478.
    CrossrefPubMedSearch in Google Scholar
  • 31 Milstone J. H. 1964; Thrombokinase as prime activator of prothrombin: historical perspectives and present status. Federation Proceedings 23: 742.
    PubMedSearch in Google Scholar
  • 32 Monto R. W, Griest W. D, Szilagyi D. E. 1952; Essential thrombophilia. Archives of Internal Medicine 90: 54.
    CrossrefPubMedSearch in Google Scholar
  • 33 Neemeh J. A, Bowie E. J. W, Thompson Fr J. H, Didisheim P, Owen Jr C. A. 1972; Quantitation of platelet aggregation in myeloproliferative disorders. American Journal of Clinical Pathology 57: 336.
    CrossrefPubMedSearch in Google Scholar
  • 34 Nygaard K. K, Brown G. E. 1937; Essential thrombophilia. Archives of Internal Medicine 59: 83.
    PubMedSearch in Google Scholar
  • 35 Ozer F. L, Truax W. E, Miesch D. C, Levin W. C. 1960; Primary hemorrhagic thrombocythemia. American Journal of Medicine 28: 807.
    CrossrefPubMedSearch in Google Scholar
  • 36 Preston F. E, Emmanuel I. G, Winfield D. A, Malia R. G. 1974; Essential thrombocythaemia and peripheral gangrene. British Medical Journal 3: 548.
    CrossrefPubMedSearch in Google Scholar
  • 37 Rigby P. G, Leavell B. S. 1960; Polycythemia vera. Archives of Internal Medicine 5: 100.
    PubMedSearch in Google Scholar
  • 38 Spaet T. H, Lejnieks I, Gaynor E, Goldstein M. L. 1969; Defective platelets in essential thrombocythemia. Archives of Internal Medicine 124: 135.
    CrossrefPubMedSearch in Google Scholar
  • 39 Takácsi-Nagy L, Gráf F. 1975; Definition, clinical features and diagnosis of myelofibrosis. Clinics in Haematology 4: 291.
    PubMedSearch in Google Scholar
  • 40 Taylor D. D, Senhauser D. A, Cavazos F. 1968; Thrombocytopathy associated with nonleukemic megakaryocytic myelosis. Functional and fine structure observations of the abnormal platelets. The American Journal of Clinical Pathology 49: 662.
    PubMedSearch in Google Scholar
  • 41 Vreeken J, Van Aken W. G. 1971; Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet II: 1394.
    PubMedSearch in Google Scholar
  • 42 Walsh P. N. 1972; a Albumin density gradient separation and washing of platelets and the study of platelet coagulant activities. British Journal of Haematology 22: 205.
    CrossrefPubMedSearch in Google Scholar
  • 43 Walsh P. N. 1972; b The effect of dilution of plasma on coagulation. The significance of the dilution – activation phenomenon for the study of platelet coagulant activities. British Journal of Haematology 22: 219.
    CrossrefPubMedSearch in Google Scholar
  • 44 Walsh P. N. 1972; c The role of platelets in the contact phase of blood coagulation. British Journal of Haematology 22: 237.
    CrossrefPubMedSearch in Google Scholar
  • 45 Walsh P. N. 1972; d The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII. British Journal of Haematology 22: 393.
    CrossrefPubMedSearch in Google Scholar
  • 46 Walsh P. N. 1972; e Platelet coagulant activities in thrombasthenia. British Journal of Haematology 23: 553.
    CrossrefPubMedSearch in Google Scholar
  • 47 Walsh P. N, Biggs R. 1972; The role of platelets in intrinsic factor-Xa formation. British Journal of Haematology 22: 743.
    CrossrefPubMedSearch in Google Scholar
  • 48 Walsh P. N, Mills D. C. B, Pareti F. I, Stewart G. J, Macfarlane D. E, Johnson M. E, Egan J. J. 1975; Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. British Journal of Haematology 29: 639.
    CrossrefPubMedSearch in Google Scholar
  • 49 Walsh P. N, Pareti F. I, Corbett J. J. 1976; Platelet coagulant activities and serum lipids in transient cerebral ischemia. New England Journal of Medicine 295: 854.
    CrossrefPubMedSearch in Google Scholar
  • 50 Walsh P. N, Mills D. C. B, White J. G. 1977; Metabolism and function of human platelets washed by albumin density gradient separation. British Journal of Haematology 36: 285.
    PubMedSearch in Google Scholar
  • 51 Wasserman L. R, Gilbert H. S. 1963; Surgery in polycythemia vera. The New England Journal of Medicine 269: 1226.
    CrossrefPubMedSearch in Google Scholar
  • 52 Wasserman L. R, Gilbert H. S. 1966; Complications of polycythemia vera. Seminars in Hematology 3: 199.
    PubMedSearch in Google Scholar
  • 53 Weinfeld A, Branehög I, Kutti J. 1975; Platelets in the myeloproliferative syndrome. Clinics in Haematology 4: 373.
    PubMedSearch in Google Scholar
  • 54 Zahavi J, Marder V. J. 1974; Acquired “Storage pool disease” of platelets associated with circulating antiplatelet antibodies. The American Journal of Medicine 56: 883.
    CrossrefPubMedSearch in Google Scholar
  • 55 Zucker S, Mielke C. H. 1972; Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. The Journal of Laboratory and Clinical Medicine 80: 385.
    PubMedSearch in Google Scholar